Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy

the DEMAND V study group

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science